Cargando…

Discontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trial

INTRODUCTION: Infliximab (IFX), a monoclonal chimeric antibody against tumour necrosis factor (TNF) α, is effective for induction and maintenance of remission in moderate to severe Crohn's disease. Discontinuation of IFX maintenance therapy in patients in remission should be considered in order...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buhl, Sine Schnoor, Steenholdt, Casper, Brynskov, Jørn, Thomsen, Ole Østergaard, Bendtzen, Klaus, Ainsworth, Mark Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Gastroenterology and Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275671/ https://www.ncbi.nlm.nih.gov/pubmed/25524543 http://dx.doi.org/10.1136/bmjopen-2014-005887

Ejemplares similares

Circulating Cytokines and Cytokine Receptors in Infliximab Treatment Failure Due to TNF-α Independent Crohn Disease
por: Steenholdt, Casper, et al.
Publicado: (2016)

A novel role of prognostic nutritional index in predicting the effectiveness of infliximab in Crohn's disease
por: Peng, Ziheng, et al.
Publicado: (2023)

Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn’s disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study
por: Paulides, Emma, et al.
Publicado: (2022)

Prospective randomised controlled trial of adults with perianal fistulising Crohn’s disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol
por: Gu, Bonita, et al.
Publicado: (2021)

Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohn’s disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial)
por: Papamichael, Konstantinos, et al.
Publicado: (2022)

Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn’s disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course
por: Harris, Rachel E, et al.
Publicado: (2020)

Randomised controlled trial. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: Trial design and protocol (CONSTRUCT)
por: Seagrove, Anne C, et al.
Publicado: (2014)

Acupuncture for Crohn’s disease: a protocol for systematic review and meta-analysis
por: Han, Qiang, et al.
Publicado: (2023)

PRedicting Outcomes For Crohn’s dIsease using a moLecular biomarkEr (PROFILE): protocol for a multicentre, randomised, biomarker-stratified trial
por: Parkes, Miles, et al.
Publicado: (2018)

The Crohn's disease: associated ATG16L1 variant and Salmonella invasion
por: Messer, Jeannette S, et al.
Publicado: (2013)

Predictors of necessity for endoscopic balloon dilatation in patients with Crohn’s disease-related small bowel stenosis
por: Hayashi, Yukie, et al.
Publicado: (2021)

Factors associated with poor compliance amongst hospitalized, predominantly adolescent pediatric Crohn’s disease patients
por: Cohen, Nathaniel A., et al.
Publicado: (2022)

Heterogeneity in pharmacological treatment and outcomes in Crohn’s disease patients in Catalonia: a population-based observational study
por: Brunet, Eduard, et al.
Publicado: (2022)

Identifying and understanding disease burden in patients with inflammatory bowel disease
por: Christensen, Katrine Risager, et al.
Publicado: (2022)

Granulocyte and monocyte apheresis as an adjunctive therapy to induce and maintain clinical remission in ulcerative colitis: a systematic review and meta-analysis
por: Kiss, Szabolcs, et al.
Publicado: (2021)

Diagnostic value of the antiglycoprotein-2 antibody for Crohn’s disease: a PRISMA-compliant systematic review and meta-analysis
por: Deng, Chuiwen, et al.
Publicado: (2017)

Lengthening adalimumab dosing interval in quiescent Crohn’s disease patients: protocol for the pragmatic randomised non-inferiority LADI study
por: Smits, L J T, et al.
Publicado: (2020)

Life-event stress induced by the Great East Japan Earthquake was associated with relapse in ulcerative colitis but not Crohn's disease: a retrospective cohort study
por: Shiga, Hisashi, et al.
Publicado: (2013)

Test accuracy of drug and antibody assays for predicting response to antitumour necrosis factor treatment in Crohn’s disease: a systematic review and meta-analysis
por: Freeman, Karoline, et al.
Publicado: (2017)

Control Crohn Safe with episodic adalimumab monotherapy as first-line treatment study (CoCroS): study protocol for a randomised controlled trial
por: Janssen, Laura, et al.
Publicado: (2021)

Is disease activity associated with social support and psychological distress in Crohn’s disease patients? Results of a cross-sectional study in a Chinese hospital population
por: Huang, Mengting, et al.
Publicado: (2023)

STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis
por: Quraishi, Mohammed Nabil, et al.
Publicado: (2019)

Efficacy of anti-TNF dosing interval lengthening in adolescents and young adults with inflammatory bowel disease in sustained remission (FREE-study): protocol for a partially randomised patient preference trial
por: Bouhuys, Marleen, et al.
Publicado: (2021)

Protocol for a double-blind, randomised, placebo-controlled pilot study for assessing the feasibility and efficacy of faecal microbiota transplant in a paediatric Crohn’s disease population: PediCRaFT Trial
por: Pai, Nikhil, et al.
Publicado: (2019)

A cohort study of duplicate faecal immunochemical testing in patients at risk of colorectal cancer from North-West England
por: Hunt, Natalie, et al.
Publicado: (2022)

Not Everything That Ulcerates Is Crohn's Disease
por: Afecto, Edgar, et al.
Publicado: (2022)

Effects of ileocolonic delivered vitamin B(2), B(3) and C (ColoVit) or the Groningen anti-inflammatory diet on disease course and microbiome of patients with Crohn’s disease (VITA-GrAID study): a protocol for a randomised and partially blinded trial
por: Otten, Antonius Timotheus, et al.
Publicado: (2023)

Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study
por: Attauabi, Mohamed, et al.
Publicado: (2022)

Observational longitudinal multicentre investigation of acute pancreatitis (GOULASH PLUS): follow-up of the GOULASH study, protocol
por: Mikó, Alexandra, et al.
Publicado: (2019)

LIFEStyle, Prevention and Risk of Acute PaNcreatitis (LIFESPAN): protocol of a multicentre and multinational observational case–control study
por: Koncz, Balázs, et al.
Publicado: (2020)

An Unusual Endoscopic Finding of Gastric Crohn's Disease
por: Garrido, Isabel, et al.
Publicado: (2021)

Endoscopic sphincterotoMy for delayIng choLecystectomy in mild acute biliarY pancreatitis (EMILY study): protocol of a multicentre randomised clinical trial
por: Kucserik, Levente Pál, et al.
Publicado: (2019)

High versus low energy administration in the early phase of acute pancreatitis (GOULASH trial): protocol of a multicentre randomised double-blind clinical trial
por: Márta, Katalin, et al.
Publicado: (2017)

Recompensation factors for patients with decompensated cirrhosis: a multicentre retrospective case–control study
por: Xu, Xiaomei, et al.
Publicado: (2021)

Cardiovascular risk factors in coeliac disease (ARCTIC): a protocol of multicentre series of studies
por: Vereczkei, Zsófia, et al.
Publicado: (2023)

Australia IBD Microbiome (AIM) Study: protocol for a multicentre longitudinal prospective cohort study
por: Williams, Astrid-Jane, et al.
Publicado: (2021)

Preadmission glucocorticoid use and anastomotic leakage after colon and rectal cancer resections: a Danish cohort study
por: Ostenfeld, Eva Bjerre, et al.
Publicado: (2015)

Multicentre prospective observational study protocol for radiation exposure from gastrointestinal fluoroscopic procedures (REX-GI study)
por: Nishida, Tsutomu, et al.
Publicado: (2020)

Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: study protocol for a multicentre randomised controlled trial
por: Pan, Shutao, et al.
Publicado: (2022)

Small Bowel Stricture Mimicking Megacolon in a Patient with Crohn's Disease
por: Fernandes, Samuel Raimundo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rtha05i0hip9v2v65qetss2g5v